Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats

Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants

(2015) Pamela T. Wong et al.   PLoS One

Formulation and Characterization of Nanoemulsion Intranasal Adjuvants: Effects of Surfactant Composition on Mucoadhesion and Immunogenicity

(2013) Pamela T. Wong et al.   MOLECULAR PHARMACEUTICS

Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells

(2013) J. Loebbermann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Intranasal immunization with W805EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model

(2013) Crystal Passmore et al.   Human Vaccines & Immunotherapeutics

Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking

(2012) Paul E. Makidon et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen

(2012) Su He Wang et al.   Nanomedicine

Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine

(2012) Subash C. Das et al.   VACCINE

The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease

(2012) Christine A. Shaw et al.   VACCINE

An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice

(2012) Anu Cherukuri et al.   Immunity & Ageing

Intranasal Immunization of Ferrets with Commercial Trivalent Influenza Vaccines Formulated in a Nanoemulsion-Based Adjuvant

(2011) Tarek Hamouda et al.   Clinical and Vaccine Immunology

Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006

(2011) Lauren J. Stockman et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease

(2011) Dennis M. Lindell et al.   PLoS One

Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens

(2011) L.R. Stanberry et al.   VACCINE

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

(2011) Peter L. Collins et al.   VIRUS RESEARCH

Efficacy, immunogenicity and stability of a novel intranasal Nanoemulsion-adjuvanted influenza vaccine in a murine model

(2010) Tarek Hamouda et al.   Human vaccines & immunotherapeutics

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Characterization of Stability and Nasal Delivery Systems for Immunization with Nanoemulsion-Based Vaccines

(2009) Paul E. Makidon et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nasal Immunization with a Recombinant HIV gp120 and Nanoemulsion Adjuvant Produces Th1 Polarized Responses and Neutralizing Antibodies to Primary HIV Type 1 Isolates

(2008) Anna U. Bielinska et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Influenza and respiratory syncytial virus in the elderly

(2008) Alex J Elliot et al.   Expert Review of Vaccines

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE

Risk Factors for Severe Respiratory Syncytial Virus Disease in Children With Cancer: The Importance of Lymphopenia and Young Age

(2008) C. M. El Saleeby et al.   PEDIATRICS

Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine

(2008) Paul E. Makidon et al.   PLoS One